Literature DB >> 10438919

Phospho-LAT-independent activation of the ras-mitogen-activated protein kinase pathway: a differential recruitment model of TCR partial agonist signaling.

L A Chau1, J Madrenas.   

Abstract

Stimulation of mature T cells with agonist ligands of the Ag receptor (TCR) causes rapid phosphorylation of tyrosine-based activation motifs in the intracellular portion of TCR-zeta and CD3 and activation of several intracellular signaling cascades. Coordinate activation of these pathways is dependent on Lck- and ZAP-70-mediated tyrosine phosphorylation of a 36-kDa linker for activation of T cells and subsequent recruitment of phospholipase C-gamma1, Grb2-SOS, and SLP-76-vav. Here, we show that TCR partial agonist ligands can selectively activate one of these pathways, the Ras-mitogen-activated protein kinase pathway, by inducing recruitment of Grb2-SOS complexes to incompletely phosphorylated p21 phospho-TCR-zeta. This bypasses the need for activation of Lck and ZAP-70, and for phosphorylation of the linker for activation of T cells to activate Ras. We propose a general model in which differential recruitment of activating complexes away from transmembrane linker proteins may determine selective activation of a given signaling pathway.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10438919

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  The importance of LAT in the activation, homeostasis, and regulatory function of T cells.

Authors:  Shudan Shen; Mariana I Chuck; Minghua Zhu; Deirdre M Fuller; Chih-Wen Ou Yang; Weiguo Zhang
Journal:  J Biol Chem       Date:  2010-09-13       Impact factor: 5.157

Review 2.  The LAT story: a tale of cooperativity, coordination, and choreography.

Authors:  Lakshmi Balagopalan; Nathan P Coussens; Eilon Sherman; Lawrence E Samelson; Connie L Sommers
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-07-07       Impact factor: 10.005

Review 3.  Molecular mechanisms for adaptive tolerance and other T cell anergy models.

Authors:  Seeyoung Choi; Ronald H Schwartz
Journal:  Semin Immunol       Date:  2007-04-02       Impact factor: 11.130

4.  Zap-70-independent Ca(2+) mobilization and Erk activation in Jurkat T cells in response to T-cell antigen receptor ligation.

Authors:  X Shan; R Balakir; G Criado; J S Wood; M C Seminario; J Madrenas; R L Wange
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

5.  The essential role of LAT in thymocyte development during transition from the double-positive to single-positive stage.

Authors:  Shudan Shen; Minghua Zhu; Jasmine Lau; Mariana Chuck; Weiguo Zhang
Journal:  J Immunol       Date:  2009-05-01       Impact factor: 5.422

6.  The importance of the Erk pathway in the development of linker for activation of T cells-mediated autoimmunity.

Authors:  Deirdre M Fuller; Minghua Zhu; Surapong Koonpaew; Mariana I Nelson; Weiguo Zhang
Journal:  J Immunol       Date:  2012-09-14       Impact factor: 5.422

7.  Selective regulation of TCR signaling pathways by the CD45 protein tyrosine phosphatase during thymocyte development.

Authors:  Rustom Falahati; David Leitenberg
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

Review 8.  Ras and extracellular signal-regulated kinase signaling in thymocytes and T cells.

Authors:  Robert L Kortum; Alexandre K Rouquette-Jazdanian; Lawrence E Samelson
Journal:  Trends Immunol       Date:  2013-03-15       Impact factor: 16.687

9.  Role of LAT in the granule-mediated cytotoxicity of CD8 T cells.

Authors:  Chih-wen Ou-Yang; Minghua Zhu; Deirdre M Fuller; Sarah A Sullivan; Mariana I Chuck; Sarah Ogden; Qi-Jing Li; Weiguo Zhang
Journal:  Mol Cell Biol       Date:  2012-05-07       Impact factor: 4.272

10.  CD45-associated protein promotes the response of primary CD4 T cells to low-potency T-cell receptor (TCR) stimulation and facilitates CD45 association with CD3/TCR and lck.

Authors:  David Leitenberg; Rustom Falahati; Dan Dan Lu; Akiko Takeda
Journal:  Immunology       Date:  2007-04-12       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.